Walgreen Agrees to Buy USA Drug Chain for $438 Million
Walgreen will purchase the stock of Stephen L. LaFrance Holdings Inc., which owns most of the acquired business, according to a statement today.
The transaction gives Walgreen 144 stores under brands including Super D Drug and May’s Drug, as well as corporate offices and a distribution center in Arkansas. It’s Walgreen’s second deal in about two weeks, after the Deerfield, Illinois- based company agreed to buy a 45 percent stake in Alliance Boots GmbH for $6.7 billion last month to expand globally.
“They’re trying to really, really dominate the U.S. pharmaceutical scene,” Brian Sozzi, an independent analyst in New York, said in an interview. “It’s just a lot of stuff going on with this company where I don’t know if they have the personnel to integrate all these businesses at once.”
The USA Drug chain had sales of $825 million in 2011, according to the statement. The transaction, expected to close in September, won’t have a material impact on Walgreen’s earnings per share for fiscal year 2012, the companies said.
Walgreen rose 0.9 percent to $29.87 at the close in New York. The shares have dropped 9.6 percent this year.
“They’re levering up the balance sheet and that’s another big concern,” Sozzi said.
Walgreen, which has about 7,890 drugstores in the U.S., had about $2.4 billion in total debt as of May 31.
To contact the editor responsible for this story: Robin Ajello at firstname.lastname@example.org
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.